New trial data shows that Pfizer's updated COVID booster shot is more powerful against Omicron subvariants than the original shot, the company announced Thursday.
Oct 14, 2022
0
11
The European Medicines Agency on Friday recommended the authorization of a dengue vaccine made by the Japanese pharmaceutical Takeda that could provide a new tool for millions worldwide against the potentially fatal disease.
Oct 14, 2022
0
21
The original COVID-19 boosters did a great job of preventing severe illness and hospitalization, even during the delta surge. Then came omicron and its subvariants, which are more transmissible than previous variants and ...
Oct 7, 2022
0
4
Testing on humans of a novel COVID-19 vaccine developed in Brazil will begin this year. It performed well in animal trials, as reported in an article published in August in Nature Communications. The scientists responsible ...
Oct 6, 2022
0
10
The U.K. conducted world-leading COVID-19 research and was the first country to find a treatment that worked, so why did it also have such a high death rate?
Sep 27, 2022
0
14
France became the latest country on Tuesday to authorize new COVID-19 vaccines that have been updated to target Omicron subvariants ahead of autumn booster campaign.
Sep 20, 2022
0
9
A vaccine candidate called R21 has been shown to be up to 80% effective at preventing malaria in young children, according to the latest trial results.
Sep 15, 2022
0
6
When the mRNA COVID-19 vaccines were first unveiled in December 2020, medical experts touted the benefits of this new technology, saying formulations could easily be tweaked someday to match a quickly changing virus. That ...
Sep 15, 2022
0
6
The COVID-19 booster shots are well tolerated by both pregnant and nursing women, a new study published Sept. 8 in JAMA Network Open concluded.
Sep 13, 2022
0
49
Researchers from the University of Oxford and their partners have today reported new findings from their Phase 2b trial following the administration of a booster dose of the candidate malaria vaccine, R21/Matrix-M—which ...
Sep 11, 2022
0
5
